Cristóbal Costoya

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling

Ido Yofe, Tomer Landsberger, Adam Yalin et al. · Nature Cancer · 2022 · 72 citations

Medicine, Immunology, Oncology +17

Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans

José M. Vicencio, Rachel Evans, R. Green et al. · Cell Death and Disease · 2022 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8+ T Cell Priming

Bernardita Medel, Cristóbal Costoya, Dominique Fernández et al. · Frontiers in Immunology · 2019 · 28 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

Felipe Gálvez‐Cancino, Mariela Navarrete, Gordon Beattie et al. · Immunity · 2025 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17